0.43USD
58.23 MUSD
321.48 MUSD
112.98 M
About MiMedx Group, Inc
Sector
Industry
CEO
Joseph H. Capper
Website
Headquarters
Marietta
Employees (FY)
895
Founded
1985
FIGI
BBG000RJ6FL5
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MDXG is 6.43 USD — it has decreased by 1.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MiMedx Group, Inc stocks are traded under the ticker MDXG.
MiMedx Group, Inc is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
MDXG stock is 2.28% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is MiMedx Group, Inc there?
MDXG earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.05 USD resulting in a 30.43% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about MiMedx Group, Inc earnings.
MiMedx Group, Inc revenue for the last quarter amounts to 81.71 M USD despite the estimated figure of 76.87 M USD. In the next quarter revenue is expected to reach 85.12 M USD.
Yes, you can track MiMedx Group, Inc financials in yearly and quarterly reports right on TradingView.
MDXG stock has risen by 2.55% compared to the previous week, the month change is a 20.12% fall, over the last year MiMedx Group, Inc has showed a 72.39% increase.
MDXG net income for the last quarter is 53.48 M USD, while the quarter before that showed 8.53 M USD of net income which accounts for 526.62% change. Track more MiMedx Group, Inc financial stats to get the full picture.
Today MiMedx Group, Inc has the market capitalization of 956.70 M, it has increased by 2.09% over the last week.
No, MDXG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MiMedx Group, Inc stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 895.00 employees. See our rating of the largest employees — is MiMedx Group, Inc on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MiMedx Group, Inc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MiMedx Group, Inc stock shows the neutral signal. See more of MiMedx Group, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MiMedx Group, Inc future price: according to them, MDXG price has a max estimate of 14.00 USD and a min estimate of 11.00 USD. Read a more detailed MiMedx Group, Inc forecast: see what analysts think of MiMedx Group, Inc and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MiMedx Group, Inc EBITDA is 33.26 M USD, and current EBITDA margin is 12.61%. See more stats in MiMedx Group, Inc financial statements.